Doprava zdarma se Zásilkovnou nad 1 299 Kč
PPL Parcel Shop 54 Balík do ruky 74 Balíkovna 49 GLS 54 Kurýr GLS 64 Zásilkovna 44 PPL 99

Evaluation of Surrogate Endpoints

Jazyk AngličtinaAngličtina
Kniha Brožovaná
Kniha Evaluation of Surrogate Endpoints Tomasz Burzykowski
Libristo kód: 01420813
Nakladatelství Springer-Verlag New York Inc., listopadu 2010
Covers the latest research on a sensitive and controversial topic in a professional and well researc... Celý popis
? points 313 b
3 133
Skladem u dodavatele Odesíláme za 8-10 dnů

30 dní na vrácení zboží


Mohlo by vás také zajímat


Covers the latest research on a sensitive and controversial topic in a professional and well researched manner.§Provides practical outlook as well as model guidelines and software tools that should be of interest to people who use the software tools described and those who do not.§Related title by Co-author Geert Molenbergh has sold more than 3500 copies world wide.§Provides dual viewpoints: from scientists in the industry as well as regulatory authorities.Both humanitarian and commercial considerations have spurred intensive search for methods to reduce the time and cost required to develop new therapies. The identification and use of surrogate endpoints, i.e., measures that can replace or supplement other endpoints in evaluations of experimental treatments or other interventions, is a general strategy that has stimulated both enthusiasm and skepticism. Surrogate endpoints are useful when they can be measured earlier, more conveniently, or more frequently than the "true" endpoints of primary interest. Regulatory agencies around the globe, particularly in the United States, Europe, and Japan, are introducing provisions and policies relating to the use of surrogate endpoints in registration studies. But how can one establish the adequacy of a surrogate? What kind of evidence is needed, and what statistical methods portray that evidence most appropriately? §This book offers a balanced account on this controversial topic. The text presents major developments of the last couple of decades, together with a unified, meta-analytic framework within which surrogates can be evaluated from several angles. Methodological development is coupled with perspectives on various therapeutic areas. Academic views are juxtaposed with standpoints of scientists working in the biopharmaceutical industry as well as of colleagues from the regulatory authorities.§Tomasz Burzykowski is Assistant Professor of Biostatistics at the Limburgs Universitair Centrum in Belgium. Dr. Burzykowski has published methodological work on the analysis of survey data, meta-analyses of clinical trials, and validation of surrogate endpoints. He is a co-author of numerous papers applying statistical methods to clinical data in different disease areas (cancer, cardiovascular diseases, dermatology, orthodontics).§Geert Molenberghs is Professor of Biostatistics at the Limburgs Universitair Centrum in Belgium. Dr. Molenberghs published methodological work on surrogate markers in clinical trials, categorical data, longitudinal data analysis, and on the analysis of non-response in clinical and epidemiological studies. He serves as Joint Editor for Applied Statistics (2001-2004) and is President of the International Biometric Society (2004-2005). He was elected Fellow of the American Statistical Association and received the Guy Medal in Bronze from the Royal Statistical Society. §Marc Buyse founded the International Drug Development Institute in 1991. He is Past President of the International Society for Clinical Biostatistics, Past President of the Quetelet Society, and Past Board Member of the Society for Clinical Trials. He is currently the Executive Director of IDDI (International Drug Development Institute) and Associate Professor of biostatistics at the Limburgs Universitair Centrum, Center for Statistics, Diepenbeek, Belgium. He has published extensively in the fields of biostatistics and oncology. His research interests include meta-analysis, surrogate endpoints, statistical detection of fraud, and the design and statistical analysis of clinical trials.

Informace o knize

Plný název Evaluation of Surrogate Endpoints
Jazyk Angličtina
Vazba Kniha - Brožovaná
Datum vydání 2010
Počet stran 410
EAN 9781441919069
ISBN 1441919066
Libristo kód 01420813
Váha 664
Rozměry 155 x 23 x 24
Darujte tuto knihu ještě dnes
Je to snadné
1 Přidejte knihu do košíku a zvolte doručit jako dárek 2 Obratem vám zašleme poukaz 3 Kniha dorazí na adresu obdarovaného

Přihlášení

Přihlaste se ke svému účtu. Ještě nemáte Libristo účet? Vytvořte si ho nyní!

 
povinné
povinné

Nemáte účet? Získejte výhody Libristo účtu!

Díky Libristo účtu budete mít vše pod kontrolou.

Vytvořit Libristo účet